Company: INMB
Filing Date: 2025-06-30
Form Type: 424B5
Source: 0001213900-25-059298
Chunk: 38

Company: Inmune Bio, Inc.
Filing Date: 2025-06-30
Form: 424B5
Chunk 38
---
 file a post-effective amendment that indicates
the termination of the offering of the common stock made by this prospectus and will become a part of this prospectus from the date that
such documents are filed with the SEC. Information in such future filings updates and supplements the information provided in this prospectus.
Any statements in any such future filings will automatically be deemed to modify and supersede any information in any document we previously
filed with the SEC that is incorporated or deemed to be incorporated herein by reference to the extent that statements in the later filed
document modify or replace such earlier statements.

Notwithstanding the foregoing,
information furnished under Items 2.02 and 7.01 of any Current Report on Form 8-K, including the related exhibits, is not incorporated
by reference in this prospectus.

The information about us contained
in this prospectus should be read together with the information in the documents incorporated by reference. You may request a copy of
any or all of these filings, at no cost, by writing or telephoning us at: David Moss, INmune Bio Inc., 1200 Prospect Street, Suite 525,
La Jolla, CA 92037, telephone number (858) 964-3720.

<div align='center'>14

INMUNE BIO INC.

PROSPECTUS SUPPLEMENT

3,000,000 Shares of Common Stock

Sole Placement Agent

A.G.P.

June 30, 2025</div>